Skip to main content

Table 1 Chromatographic conditions

From: Stability-indicating RP-HPLC method development and validation for simultaneous estimation of telmisartan and rosuvastatin calcium in bulk and in tablet dosage form

Parameters Results
Type of system HPLC with UV detector or equivalent
Pump mode Isocratic
Mobile phase 10 mM phosphate buffer with 1.1 g octane-1-sulfonic acid sodium salt having pH 2.5 (adjusted with 5% OPA) and Acetonitrile (500:500, v/v)
Column Oyster ODS3 (5 µm, 4.6 × 150 mm) P/N: S670153 (Make: Merck & Co.)
Injection   volume 20 µL
Run time 9 min
Flow rate 1.0 mL/min
Detection 242.0 nm
Column temperature Ambient (about 25 °C)
Blank Diluent